Boston Scientific Corp (BSX)

[musicalchairs]

This is the bad news report on a down day at the street. No doubt BSX will take measures to restore profit to the bottom line. Nice time to jump in..........

Shares of Boston Scientific Corp. ($8.46, -$1.70, -16.73%) dropped after the company pointed to challenges facing markets for its top heart devices, implantable defibrillators and drug-coated stents. The company issued weaker results than Wall Street expected late Monday while it sliced its full-year earnings guidance. On a long conference call Tuesday, the company noted pressure on device prices and the potential negative impact of recent stent studies, plus a softened growth outlook within the market for heart-rhythm devices. Shares of St. Jude Medical Inc. (STJ, $32.50, -$1.78, -5.19%) also fell. -Dow Jones